Seeking Alpha

MannKind Corp. (MNKD)

()

News & PR
Market Currents

Buzz
Twitter: MNKD

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Tuesday Options Recap

Dec 22 • Frederic Ruffy • Comment!
Monday Options Update: AA, UUP, MNKD & LVLT

Dec 21 • Andrew Wilkinson • Comment!
Diabetes Care: Global Investing Opportunities

Nov 22 • Mike Havrilla • 4 Comments
Oral-lyn vs. Afresa: How Generex Will Beat Mannkind

Nov 19 • R.J Steffens • 18 Comments
Wall Street Breakfast: Must-Know News

Nov 3 • SA Editor Eli Hoffmann • 16 Comments
BioMed News: Rockwell Medical, EXACT Sciences, MannKind

Oct 30 • Mike Havrilla • Comment!
Liking the Risk/Reward in Generex

Oct 12 • VFC's Stock House • 3 Comments
Why I'm Taking a Foothold in Generex Now

Oct 12 • VFC's Stock House • 4 Comments
BioMimetic Leads Tuesday's Healthcare Winners

Oct 7 • M. E. Garza • Comment!
Equities Roundup: The Wizards of Oz

Oct 6 • Midnight Trader • 7 Comments
Biotech Discounts Galore

Aug 9 • The Burrill Report • 1 Comment
15 Possible Healthcare Breakout Stocks

Jun 21 • Marco Hickey • 9 Comments
Aradigm: Hard to Value, But Significant Upside

Jun 19 • Zacks.com • 1 Comment
Bio Medical Stock Sector is Where the Action Is

Jun 9 • M. E. Garza • Comment!
Emisphere: Improving Drug Delivery

Jun 5 • Mike Havrilla • 6 Comments
FDA and Clinical Trial Updates: United Therapeutics Faces Delays

Mar 18 • Mike Havrilla • 1 Comment
Pharmas and Biotech: Vying for Outsize Insulin Profits

Nov 20, 2008 • SA Editor Judy Weil • 2 Comments
Biotech Outlook: M&A Will Continue

Sep 2, 2008 • Zacks.com • 2 Comments
BioMarin, Myriad, and Regeneron Show a Quiet Strength

Jun 26, 2008 • Zacks.com • Comment!
Mannkind: Overlooked Biotech With Excellent Prospects (Part VI)

Jun 22, 2008 • Ahithophel Weissberger • 38 Comments
Mannkind: Overlooked Biotech With Excellent Prospects (Part V)

Jun 19, 2008 • Ahithophel Weissberger • 11 Comments
Mannkind: Overlooked Biotech With Excellent Prospects (Part IV)

Jun 17, 2008 • Ahithophel Weissberger • 16 Comments
Mannkind: Overlooked Biotech With Excellent Prospects (Part III)

Jun 13, 2008 • Ahithophel Weissberger • 28 Comments
Mannkind: Overlooked Biotech With Excellent Prospects (Part II)

Jun 11, 2008 • Ahithophel Weissberger • 14 Comments
ADA's 68th Scientific Sessions: A New Look at Insulin Therapy

Jun 10, 2008 • R.J Steffens • 8 Comments
Mannkind: Overlooked Biotech With Excellent Prospects (Part I)

Jun 8, 2008 • Ahithophel Weissberger • 10 Comments
Biotech Sector Continues to Outperform

May 29, 2008 • Zacks.com • Comment!
Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada

May 5, 2008 • R.J Steffens • 8 Comments
Fixing Pfizer

May 4, 2008 • Mike Huckman • 7 Comments
Generex Biotech: A Breath of Fresh Insulin

Apr 14, 2008 • Biotech Boldman • 8 Comments
Oral Insulin: Balancing Safety with Efficacy

Apr 14, 2008 • R.J Steffens • 4 Comments
MannKind: No Partnership Likely for Inhalable Insulin

Apr 11, 2008 • Mike Huckman • 4 Comments
Mannkind Slammed: No Guarantees in Drug Safety

Apr 11, 2008 • Derek Lowe • 7 Comments
Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage

Apr 10, 2008 • R.J Steffens • 13 Comments
Nektar, Mannkind Suffer from Pfizer's (Discontinued) Inhaled Insulin Effects

Apr 10, 2008 • Derek Lowe • 1 Comment
Inhaled Insulin: One Giant Leap for MannKind

Mar 11, 2008 • Mike Huckman • 5 Comments
Inhaled Insulin: Eli Lilly On Its 'Last Breath'?

Mar 9, 2008 • Mike Huckman • Comment!
Alkermes, Lilly, Mannkind: Inhaled Insulin Just Got Interesting

Jan 22, 2008 • Michael Shulman • 5 Comments
Eat It, Breathe It, Soak in It? Drug Administration Gets Tricky

Jan 20, 2008 • Derek Lowe • 1 Comment
Monday's Under The Radar News

Jan 7, 2008 • SA Editor Eli Hoffmann • Comment!
5 Stocks with Atmospheric Price Sales Ratios

Mar 12, 2007 • Stockerblog • 1 Comment

MannKind Corp. (MNKD)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers